Lorundrostat for Resistant Hypertension: What Makes It Different
Lorundrostat is under FDA review for resistant hypertension. It targets aldosterone synthase and may offer a focused approach for hard-to-control BP.
Lorundrostat is under FDA review for resistant hypertension. It targets aldosterone synthase and may offer a focused approach for hard-to-control BP.